Int. J. Mol. Sci. 2012, 13(10), 13227-13239; doi:10.3390/ijms131013227
Review

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis

Chiara Fenoglio* email, Elisa Ridolfiemail, Daniela Galimbertiemail and Elio Scarpiniemail
Department of Pathophysiology and transplantation, “Dino Ferrari” Center, University of Milan, IRCCS Foundation Cà Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy
* Author to whom correspondence should be addressed.
Received: 13 August 2012; in revised form: 27 September 2012 / Accepted: 8 October 2012 / Published: 15 October 2012
(This article belongs to the Special Issue Recent Advances in the Research of Multiple Sclerosis)
PDF Full-text Download PDF Full-Text [253 KB, Updated Version, uploaded 16 October 2012 16:34 CEST]
The original version is still available [173 KB, uploaded 15 October 2012 12:09 CEST]
Abstract: MicroRNAs (miRNAs) are a recently discovered group of small noncoding RNAs that regulate gene expression post-transcriptionally. They are highly expressed in cells of the immune system, as well as in the central nervous system, and they are deregulated in various neurological disorders. Emerging evidence underlines an involvement of miRNAs in the pathogenesis of Multiple Sclerosis (MS). A number of miRNAs have been found to be dysregulated in blood cells from MS patients, in brain lesions, as well as in biological fluids such as serum and plasma. Despite miRNA altered expression likely showing a high tissue specificity, some profile similarities could be observed for certain miRNAs such as miR-326—such as upregulation in both active lesions and blood—though not for others such as miR-323, which demonstrated upregulation in whole blood, active brain lesions, and T-reg cells, but not in the serum of MS patients. In this review, the possible role of miRNAs in MS pathogenesis will be discussed according to all the available literature, with a particular emphasis on the possibility of considering extracellular miRNAs as a new source for both biomarker identification and therapeutic target discovery.
Keywords: multiple sclerosis; microRNA; immune system; biomarker; central nervous system

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Fenoglio, C.; Ridolfi, E.; Galimberti, D.; Scarpini, E. MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis. Int. J. Mol. Sci. 2012, 13, 13227-13239.

AMA Style

Fenoglio C, Ridolfi E, Galimberti D, Scarpini E. MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis. International Journal of Molecular Sciences. 2012; 13(10):13227-13239.

Chicago/Turabian Style

Fenoglio, Chiara; Ridolfi, Elisa; Galimberti, Daniela; Scarpini, Elio. 2012. "MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis." Int. J. Mol. Sci. 13, no. 10: 13227-13239.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert